During the past decade, PCSD Feighner Research conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 17 clinical trials were completed, i.e. on average, 106.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 9 clinical trials were completed. i.e. 225% of trials that started reached the finish line.

Out of the total clinical trials conducted in "PCSD Feighner Research" #1 sponsor was "Shire" with 11 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Forest Laboratories" with 3 trials sponsored, "Naurex, Inc, an affiliate of Allergan plc" with 3 trials sponsored and "Sunovion" with 3 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "PCSD Feighner Research" #1 collaborator was "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "PCSD Feighner Research" are "Binge Eating Disorder" (5 trials), "Major Depressive Disorder" (5 trials), "Autism Spectrum Disorder" (4 trials), "Depressive Disorder, Major" (3 trials) and "Attention Deficit Hyperactivity Disorder" (2 trials). Many other conditions were trialed in "PCSD Feighner Research" in a lesser frequency.

Most popular intervention types in "PCSD Feighner Research" are "Drug" (28 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Lisdexamfetamine dimesylate" (3 trials), "Rapastinel" (3 trials), "Dasotraline" (2 trials) and "Ecopipam" (2 trials). Other intervention names were less common.

The vast majority of trials in "PCSD Feighner Research" are 28 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "PCSD Feighner Research". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in PCSD Feighner Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in PCSD Feighner Research, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".